Max Healthcare Institute Limited
Max Healthcare Institute Limited provides medical and healthcare services in India. It offers services in various specialties, including cardiac sciences, orthopedics, oncology, renal sciences, neurosciences, minimal access and general surgery, pulmonology, obstetrics, gynecology, pediatrics, and nephrology, liver and biliary sciences, gastroenterology and Gi surgery, plastic and reconstructive s… Read more
Max Healthcare Institute Limited (MAXHEALTH) - Net Assets
Latest net assets as of September 2025: ₹100.52 Billion INR
Based on the latest financial reports, Max Healthcare Institute Limited (MAXHEALTH) has net assets worth ₹100.52 Billion INR as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₹162.81 Billion) and total liabilities (₹62.29 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₹100.52 Billion |
| % of Total Assets | 61.74% |
| Annual Growth Rate | 29.44% |
| 5-Year Change | 66.37% |
| 10-Year Change | 731.48% |
| Growth Volatility | 132.87 |
Max Healthcare Institute Limited - Net Assets Trend (2014–2025)
This chart illustrates how Max Healthcare Institute Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Max Healthcare Institute Limited (2014–2025)
The table below shows the annual net assets of Max Healthcare Institute Limited from 2014 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | ₹93.81 Billion | +11.57% |
| 2024-03-31 | ₹84.08 Billion | +13.48% |
| 2023-03-31 | ₹74.10 Billion | +17.94% |
| 2022-03-31 | ₹62.82 Billion | +11.42% |
| 2021-03-31 | ₹56.39 Billion | +471.06% |
| 2020-03-31 | ₹9.87 Billion | +2.51% |
| 2019-03-31 | ₹9.63 Billion | -6.85% |
| 2018-03-31 | ₹10.34 Billion | -6.51% |
| 2017-03-31 | ₹11.06 Billion | -1.97% |
| 2016-03-31 | ₹11.28 Billion | +30.74% |
| 2015-03-31 | ₹8.63 Billion | +57.19% |
| 2014-03-31 | ₹5.49 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Max Healthcare Institute Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 3524660000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₹31.11 Billion | 33.16% |
| Common Stock | ₹9.72 Billion | 10.36% |
| Other Comprehensive Income | ₹1.14 Billion | 1.21% |
| Other Components | ₹51.84 Billion | 55.26% |
| Total Equity | ₹93.81 Billion | 100.00% |
Max Healthcare Institute Limited Competitors by Market Cap
The table below lists competitors of Max Healthcare Institute Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Bangkok Bank PCL
BK:BBL
|
$7.97 Billion |
|
Chifeng Jilong Gold Mining Co Ltd
SHG:600988
|
$7.99 Billion |
|
SEI Investments Company
NASDAQ:SEIC
|
$7.99 Billion |
|
Element Fleet Management Corp
PINK:ELEEF
|
$7.99 Billion |
|
CEMEX S.A.B. de C.V
PINK:CXMSF
|
$7.97 Billion |
|
Bid Corporation Limited
PINK:BPPPF
|
$7.96 Billion |
|
The Interpublic Group of Companies Inc
MU:IPG
|
$7.96 Billion |
|
Britannia Industries Limited
NSE:BRITANNIA
|
$7.95 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Max Healthcare Institute Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 84,081,400,000 to 93,808,700,000, a change of 9,727,300,000 (11.6%).
- Net income of 10,758,800,000 contributed positively to equity growth.
- Dividend payments of 1,455,800,000 reduced retained earnings.
- New share issuances of 2,300,000 increased equity.
- Other comprehensive income increased equity by 476,400,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₹10.76 Billion | +11.47% |
| Dividends Paid | ₹1.46 Billion | -1.55% |
| Share Issuances | ₹2.30 Million | +0.0% |
| Other Comprehensive Income | ₹476.40 Million | +0.51% |
| Other Changes | ₹-54.40 Million | -0.06% |
| Total Change | ₹- | 11.57% |
Book Value vs Market Value Analysis
This analysis compares Max Healthcare Institute Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 10.31x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 74.48x to 10.31x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-03-31 | ₹13.29 | ₹990.00 | x |
| 2015-03-31 | ₹19.13 | ₹990.00 | x |
| 2016-03-31 | ₹20.67 | ₹990.00 | x |
| 2017-03-31 | ₹20.27 | ₹990.00 | x |
| 2018-03-31 | ₹18.95 | ₹990.00 | x |
| 2019-03-31 | ₹17.65 | ₹990.00 | x |
| 2020-03-31 | ₹18.38 | ₹990.00 | x |
| 2021-03-31 | ₹65.32 | ₹990.00 | x |
| 2022-03-31 | ₹64.81 | ₹990.00 | x |
| 2023-03-31 | ₹76.25 | ₹990.00 | x |
| 2024-03-31 | ₹86.20 | ₹990.00 | x |
| 2025-03-31 | ₹96.00 | ₹990.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Max Healthcare Institute Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 11.47%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 15.31%
- • Asset Turnover: 0.46x
- • Equity Multiplier: 1.62x
- Recent ROE (11.47%) is above the historical average (2.75%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -11.78% | -6.85% | 0.74x | 2.33x | ₹-1.20 Billion |
| 2015 | -4.42% | -4.83% | 0.53x | 1.73x | ₹-1.24 Billion |
| 2016 | -2.00% | -1.58% | 0.47x | 2.70x | ₹-1.35 Billion |
| 2017 | 1.43% | 0.98% | 0.51x | 2.85x | ₹-948.05 Million |
| 2018 | -2.01% | -1.20% | 0.52x | 3.21x | ₹-1.24 Billion |
| 2019 | -0.31% | -0.18% | 0.50x | 3.49x | ₹-993.29 Million |
| 2020 | 5.97% | 5.57% | 0.28x | 3.87x | ₹-397.51 Million |
| 2021 | -2.44% | -5.48% | 0.29x | 1.52x | ₹-7.01 Billion |
| 2022 | 9.63% | 15.37% | 0.43x | 1.46x | ₹-231.97 Million |
| 2023 | 14.89% | 24.19% | 0.45x | 1.36x | ₹3.63 Billion |
| 2024 | 12.58% | 19.56% | 0.45x | 1.43x | ₹2.17 Billion |
| 2025 | 11.47% | 15.31% | 0.46x | 1.62x | ₹1.38 Billion |
Industry Comparison
This section compares Max Healthcare Institute Limited's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $13,494,104,361
- Average return on equity (ROE) among peers: 8.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Max Healthcare Institute Limited (MAXHEALTH) | ₹100.52 Billion | -11.78% | 0.62x | $7.97 Billion |
| Apollo Hospitals Enterprise Limited (APOLLOHOSP) | $48.02 Billion | 3.13% | 1.38x | $8.72 Billion |
| Aster DM Healthcare Limited (ASTERDM) | $8.87 Billion | 5.90% | 0.85x | $1.48 Billion |
| Fortis Healthcare Limited (FORTIS) | $40.85 Billion | 1.77% | 2.04x | $4.64 Billion |
| GPT Healthcare Ltd (GPTHEALTH) | $2.18 Billion | 21.86% | 0.58x | $37.86 Million |
| Healthcare Global Enterprises Limited (HCG) | $2.96 Billion | -3.55% | 1.40x | $307.57 Million |
| Indraprastha Medical Corporation Limited (INDRAMEDCO) | $1.59 Billion | 16.95% | 1.52x | $183.78 Million |
| Jupiter Life Line Hospitals Limited (JLHL) | $2.37 Billion | 12.52% | 1.55x | $345.52 Million |
| Krishna Institute of Medical Sciences Limited (KIMS) | $14.11 Billion | 23.58% | 0.35x | $1.77 Billion |
| Lotus Eye Hospital and Institute Limited (LOTUSEYE) | $493.84 Million | -4.01% | 0.14x | $7.74 Million |